How NMN Is Absorbed and Metabolized

What "absorption" means for NMN

Absorption asks how a molecule taken by mouth gets from the digestive tract into the bloodstream and then into cells. For NMN this question has two separate parts that are easy to blur together: (1) does oral NMN raise NAD+-related measurements in the human body, and (2) exactly which molecular route it takes to get there. The first question has reasonably direct human trial evidence. The second remains an active, unresolved area of research — and this page keeps the two apart deliberately.

What's established: oral NMN raises blood NAD+ markers in humans

Multiple randomized, placebo-controlled human trials report that oral NMN supplementation increases blood NAD+ and related metabolites, typically detectable within weeks of daily dosing.[1][2] This is a real, repeatedly observed outcome — see NMN Dosage: What Human Studies Have Actually Used for the full set of trials. What these blood-marker studies do not establish on their own is the precise cellular mechanism by which that happens, or what downstream health effects, if any, follow from a higher blood NAD+ reading.

The proposed route: extracellular breakdown before uptake

NMN carries a phosphate group that makes it too large and charged to cross a cell membrane directly through ordinary diffusion. One well-supported model holds that an enzyme called CD73, sitting on the outside of cells, first strips that phosphate group off extracellular NMN, converting it into nicotinamide riboside (NR) — a smaller, uncharged molecule that established transporters can carry into the cell, where it is converted back into NMN and then into NAD+.[3] This CD73-mediated route is grounded in cell and tissue biology research rather than in a human clinical trial designed to test it directly in people.

SLC12A8: a proposed direct transporter — and an unresolved dispute

In 2019, one research group reported identifying a protein called SLC12A8 as a dedicated NMN transporter, based on experiments in mouse intestinal tissue and cell lines.[4] That same year, a separate group published a direct challenge to the finding, arguing that the underlying transport measurements and analytical methods did not support the conclusion that SLC12A8 moves NMN across membranes.[5] The original authors published a rebuttal defending their methodology, and the dispute was never definitively resolved in the literature. Two things are important to say plainly: this entire exchange concerns mouse tissue, not humans, and no study has confirmed that SLC12A8, or any other single transporter, is the operative route for NMN uptake in the human intestine. Presenting SLC12A8 as an established, settled mechanism in humans would overstate what the evidence currently shows.

What this means in practice

Put together, this leaves a specific and honest picture: human trials show that swallowing NMN is followed by higher blood NAD+ markers,[1][2] but the exact route — extracellular conversion to NR, a direct transporter such as SLC12A8, some combination, or additional routes not yet characterized — is still being worked out at the level of basic science.[3][4][5] A supplement label or marketing claim that states flatly "NMN is absorbed via SLC12A8" is describing one contested hypothesis as settled fact. For what's separately known about different NMN product forms, see NMN Powder vs Capsules; for how much NMN human trials have actually used, see the Dosage page.